Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
The Surf Club at Miami’s Four Seasons Hotel has a new member. Daniel Nadler, founder of medical AI company OpenEvidence, has just purchased a $38.2 million triplex at this exclusive seaside resort.
Nadler may be new to Florida’s high-end real estate game, but he’s certainly making up for lost time. According to The Wall Street Journal, this is the 42-year-old Canadian’s first U.S. real estate investment. This is the kind of deal you can pull off when Google backs your startup and Forbes certifies you as a billionaire.
It’s worth nothing that Nadler didn’t just come out of nowhere. He’s an established player in the tech game with a track record of success. Before founding OpenEvidence, Nadler founded Kensho Technologies, which the Journal reports he sold for $550 million in 2018.
Don’t Miss:
Nadler made his fortune by building a better mousetrap. His company, OpenEvidence, operates an AI-enhanced search engine for doctors. The company is on a hot streak. OpenEvidence announced the receipt of a $210 million round of series B funding last month. The release also claims OpenEvidence is the most widely used medical search and AI application among verified U.S. clinicians, and has a current valuation of $3.5 billion.
OpenEvidence works by utilizing proprietary algorithms to screen thousands of published medical research papers in milliseconds and directs doctors to the most relevant information. This technology can consume and process information much more quickly than doctors can by using traditional methods.
“I think OpenEvidence looks like it’s going to be for healthcare what Google was for the Internet,” billionaire investor John Doerr, told Forbes. “It’s the free-for-physician model that’s the magic here.” OpenEvidence also mirrors Google in another way. Doctors can use OpenEvidence for free, and the platform generates revenue through advertising sales.
Trending: 7 Million Gamers Already Trust Gameflip With Their Digital Assets — Now You Can Own a Stake in the Platform
It’s not hard to see why companies like Google and investors like Doerr are so hot on Nadler’s new venture. They are banking on OpenEvidence’s potential to improve patient outcomes. They stand to make a lot of money if OpenEvidence can deliver.
